(c) 2024 PillSync.com

methimazole tablet

INDICATIONS AND USAGE Methimazole is indicated: In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy

Par Pharmaceutical, Inc.

FDA Reported Adverse Reactions
[1] drug ineffective    [2] nausea    [3] fatigue    [4] diarrhoea    [5] dyspnoea    [6] headache    [7] off label use    [8] pain    [9] vomiting    [10] arthralgia   

3 years ago ROUND WHITE EM 5 methimazole tablet

ROUND WHITE EM 5

3 years ago ROUND WHITE EM 5 methimazole tablet

EM 5 ROUND WHITE

HOW SUPPLIED Methimazole Tablets, USP 5 mg - white to off-white, round, flat-faced, bevelled-edged tablets, scored with “EM/5” on one side and plain on the other. They are available in: Bottles of 100 NDC 49884-640-01 Bottles of 500 NDC 49884-640-05 Methimazole Tablets, USP 10 mg - white to off-white, round, flat-faced, bevelled-edged tablets, scored with “EM/10” on one side and plain on the other. They are available in: Bottles of 100 NDC 49884-641-01 Bottles of 500 NDC 49884-641-05 Store at controlled room temperature 15° to 30°C (59° to 86°F). Dispense in tight, light-resistant container. Manufactured and distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 Revised: 01/16 OS640-01-1-11


More pills like ROUND EM 5

Related Pills

methimazole tablet

par pharmaceutical

Methimazole Methimazole 10 MG Oral Tablet

Par Pharmaceutical Inc

Levothyroxine Sodium 0.05 MG Oral Tablet Euthyrox

provell pharmaceuticals, llc

lemborexant 5 mg

eisai inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site